Overview
- Description
The company's lead program is a pan-influenza nasal spray currently in clinical development (PanFlu), which has the potential to provide first-in-class influenza protection and meaningfully reduce the burden of influenza infection, including in infection from Avian Flu (H5).
- Website
- Country
- The Netherlands
- Sector
- Health Biotechnology